OneVentures
Team Portfolio Funds Entrepreneurs News Investors
TeamPortfolioFundsEntrepreneursNewsInvestors
OneVentures

Nanopatch vaccine technology company attracts $25 million

 
Learn More
 
University of QueenslandSanice EmbletonFebruary 10, 2015Vaxxas, Paul Kelly
Twitter LinkedIn0 0 Likes
Previous

Investors keen on biotech injection: OneVentures

The AustralianSanice EmbletonFebruary 11, 2015OneVentures, Paul Kelly, Anne-Marie Birkill, Michelle Deaker
Next

A company developing needle-free vaccination tech just raised $25 million

Business InsiderSanice EmbletonFebruary 10, 2015Vaxxas

Careers

Disclaimer

Sydney

Suite 13.02, 179 Elizabeth Sydney NSW 2000

enquiries@one-ventures.com

+61 2 8205 7379

 

 

Brisbane

The Precinct, Level 2, 315 Brunswick St Fortitude Valley QLD 4006

 

 

Melbourne

c/o FB Rice, Level 14, 90 Collins St Melbourne VIC 3000

OneVentures Pty Ltd
179 Elizabeth Street (Suite 13.02),
Sydney, NSW, 2000,
Australia
+61 2 8205 7379 enquiries@one-ventures.com
Hours

Copyright © 2017 OneVentures Pty Ltd